Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biobased Chemicals

Fujifilm expands biologics capacity in North Carolina

by Rick Mullin
January 14, 2019 | A version of this story appeared in Volume 97, Issue 2

 

Fujifilm plans to invest approximately $90 million to expand its biologics contract development and manufacturing business, Fujifilm Diosynth Biotechnologies. The project will add 2,000 L single-use cell culture manufacturing trains, cell culture purification suites, and microbial recovery suites to existing facilities in Morrisville, North Carolina. The result will be a 25% increase in cell culture production capacity and a 50% boost in microbial capacity. The new facilities are expected to be on line early next year.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.